These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24387321)

  • 41. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY; Qiao J; Link H
    J Neuroimmunol; 1993 May; 44(2):209-14. PubMed ID: 8505410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.
    Deng C; Goluszko E; Tüzün E; Yang H; Christadoss P
    J Immunol; 2002 Jul; 169(2):1077-83. PubMed ID: 12097416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
    Wang W; Ostlie NS; Conti-Fine BM; Milani M
    J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
    J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P
    J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement activation in myasthenia gravis plasma by Torpedo acetylcholine receptor liposomes.
    DuPont BL; Koethe SM; McQuillen MP
    Immunol Invest; 1985 Oct; 14(5):415-20. PubMed ID: 4077155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
    Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
    Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J mice.
    Tüzün E; Scott BG; Yang H; Wu B; Goluszko E; Guigneaux M; Higgs S; Christadoss P
    J Immunol; 2004 May; 172(9):5743-52. PubMed ID: 15100321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis.
    Garcia YR; Pothitakis JC; Krolick KA
    Clin Immunol; 2003 Feb; 106(2):116-26. PubMed ID: 12672402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LF 15-0195 prevents from the development and inhibits the progression of rat experimental autoimmune myasthenia gravis.
    Duplan V; Dutartre P; Druet P; Saoudi A
    J Neuroimmunol; 2002 Aug; 129(1-2):115-24. PubMed ID: 12161027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Grilled Nux Vomica on Differential RNA Expression Profile of Gastrocnemius Muscle and Toll‑Like Receptor 4 (TLR-4)/Nuclear Factor kappa B (NF-κB) Signaling in Experimental Autoimmune Myasthenia Gravis Rats.
    Jiang XH; Chen Y; Ding YY; Qiu H; Zhou DY; Qiu CL
    Med Sci Monit; 2020 Feb; 26():e919150. PubMed ID: 32052794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
    Ostlie N; Milani M; Wang W; Okita D; Conti-Fine BM
    J Immunol; 2003 Jan; 170(1):604-12. PubMed ID: 12496449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
    Baggi F; Antozzi C; Toscani C; Cordiglieri C
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of experimental autoimmune myasthenia gravis with acetylcholine receptors using a nonionic block copolymer as adjuvant.
    Shenoy M; Christadoss P
    Immunol Invest; 1993 Jun; 22(4):267-82. PubMed ID: 8359864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis.
    Nessi V; Nava S; Ruocco C; Toscani C; Mantegazza R; Antozzi C; Baggi F
    J Immunol; 2010 Nov; 185(9):5656-67. PubMed ID: 20881192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.